160 related articles for article (PubMed ID: 9684796)
21. Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study.
Mease PJ; Hobbs K; Chalmers A; El-Gabalawy H; Bookman A; Keystone E; Furst DE; Anklesaria P; Heald AE
Ann Rheum Dis; 2009 Aug; 68(8):1247-54. PubMed ID: 18678578
[TBL] [Abstract][Full Text] [Related]
22. Effects of activated protein C on coagulation and fibrinolysis in rabbits with endotoxin induced acute lung injury.
He HY; Wang C; Pang BS
Chin Med J (Engl); 2008 Dec; 121(24):2561-5. PubMed ID: 19187596
[TBL] [Abstract][Full Text] [Related]
23. Chronic physiological shear stress inhibits tumor necrosis factor-induced proinflammatory responses in rabbit aorta perfused ex vivo.
Yamawaki H; Lehoux S; Berk BC
Circulation; 2003 Sep; 108(13):1619-25. PubMed ID: 12963644
[TBL] [Abstract][Full Text] [Related]
24. Lowered tumor necrosis factor receptors, but not increased insulin sensitivity, with infliximab.
Di Rocco P; Manco M; Rosa G; Greco AV; Mingrone G
Obes Res; 2004 Apr; 12(4):734-9. PubMed ID: 15090644
[TBL] [Abstract][Full Text] [Related]
25. Fat emulsion infusion potentiates coagulation activation during human endotoxemia.
van der Poll T; Coyle SM; Levi M; Boermeester MA; Braxton CC; Jansen PM; Hack CE; Lowry SF
Thromb Haemost; 1996 Jan; 75(1):83-6. PubMed ID: 8713784
[TBL] [Abstract][Full Text] [Related]
26. Changes in HLA-DR expression, cytokine production and coagulation following endotoxin infusion in healthy human volunteers.
Mant TG; Borozdenkova S; Bradford DB; Allen E; Amin DM; Toothaker RD; Collins RW; Hargreaves RE; Jurcevic S
Int Immunopharmacol; 2008 May; 8(5):701-7. PubMed ID: 18387512
[TBL] [Abstract][Full Text] [Related]
27. Polymorphonuclear granulocytes enhance lipopolysaccharide-induced soluble p75 tumor necrosis factor receptor release from mononuclear cells.
Lien E; Liabakk NB; Johnsen AC; Nonstad U; Sundan A; Espevik T
Eur J Immunol; 1995 Sep; 25(9):2714-7. PubMed ID: 7589151
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of Th1 polarization by soluble TNF receptor is dependent on antigen-presenting cell-derived IL-12.
Becher B; Blain M; Giacomini PS; Antel JP
J Immunol; 1999 Jan; 162(2):684-8. PubMed ID: 9916686
[TBL] [Abstract][Full Text] [Related]
29. A recombinant tumor necrosis factor-alpha p80 receptor:Fc fusion protein decreases circulating bioactive tumor necrosis factor-alpha but not lung injury or mortality during immunosuppression-related gram-negative bacteremia.
Lechner AJ; Johanns CA; Matuschak GM
J Crit Care; 1997 Mar; 12(1):28-38. PubMed ID: 9075062
[TBL] [Abstract][Full Text] [Related]
30. Effects of IC14, an anti-CD14 antibody, on coagulation and fibrinolysis during low-grade endotoxemia in humans.
Verbon A; Meijers JC; Spek CA; Hack CE; Pribble JP; Turner T; Dekkers PE; Axtelle T; Levi M; van Deventer SJ; Reitsma PH; van der Poll T
J Infect Dis; 2003 Jan; 187(1):55-61. PubMed ID: 12508146
[TBL] [Abstract][Full Text] [Related]
31. Intra-arterial tumor necrosis factor-alpha impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humans.
Chia S; Qadan M; Newton R; Ludlam CA; Fox KA; Newby DE
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):695-701. PubMed ID: 12692009
[TBL] [Abstract][Full Text] [Related]
32. Multi-cellular activation in vivo by endotoxin in humans--limited protection by adenosine infusion.
Li N; Soop A; Sollevi A; Hjemdahl P
Thromb Haemost; 2000 Sep; 84(3):381-7. PubMed ID: 11019959
[TBL] [Abstract][Full Text] [Related]
33. Activation of coagulation after administration of tumor necrosis factor to normal subjects.
van der Poll T; Büller HR; ten Cate H; Wortel CH; Bauer KA; van Deventer SJ; Hack CE; Sauerwein HP; Rosenberg RD; ten Cate JW
N Engl J Med; 1990 Jun; 322(23):1622-7. PubMed ID: 2188129
[TBL] [Abstract][Full Text] [Related]
34. Correlation of the expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1 (TNFR 1) and c-Myc with the clinical course in the treatment of malignant astrocytomas with recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2).
Yamamoto M; Fukushima T; Hayashi S; Ikeda K; Tsugu H; Kimura H; Soma G; Tomonaga M
Anticancer Res; 2000; 20(1C):611-8. PubMed ID: 10769704
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy.
Oyajobi BO; Anderson DM; Traianedes K; Williams PJ; Yoneda T; Mundy GR
Cancer Res; 2001 Mar; 61(6):2572-8. PubMed ID: 11289133
[TBL] [Abstract][Full Text] [Related]
36. TNFR80-dependent enhancement of TNFR60-induced cell death is mediated by TNFR-associated factor 2 and is specific for TNFR60.
Weiss T; Grell M; Siemienski K; Mühlenbeck F; Dürkop H; Pfizenmaier K; Scheurich P; Wajant H
J Immunol; 1998 Sep; 161(6):3136-42. PubMed ID: 9743381
[TBL] [Abstract][Full Text] [Related]
37. Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor.
Yamada Y; Webber EM; Kirillova I; Peschon JJ; Fausto N
Hepatology; 1998 Oct; 28(4):959-70. PubMed ID: 9755232
[TBL] [Abstract][Full Text] [Related]
38. Prolongation of islet allograft survival following ex vivo transduction with adenovirus encoding a soluble type 1 TNF receptor-Ig fusion decoy.
Machen J; Bertera S; Chang Y; Bottino R; Balamurugan AN; Robbins PD; Trucco M; Giannoukakis N
Gene Ther; 2004 Oct; 11(20):1506-14. PubMed ID: 15229635
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees.
Levi M; ten Cate H; Bauer KA; van der Poll T; Edgington TS; Büller HR; van Deventer SJ; Hack CE; ten Cate JW; Rosenberg RD
J Clin Invest; 1994 Jan; 93(1):114-20. PubMed ID: 8282778
[TBL] [Abstract][Full Text] [Related]
40. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
